ARTICLE | Clinical News
Abraxane nab-paclitaxel regulatory update
January 5, 2015 8:00 AM UTC
Japan approved an expanded label for Abraxane nab-paclitaxel from Taiho to include treatment of unresectable pancreatic cancer. The albumin-stabilized nanoparticle formulation of paclitaxel is approve...